No abstract available
Keywords:
COVID-19; Crohn's Disease; Inflammatory Bowel Disease; Ulcerative Colitis; Vaccination.
MeSH terms
-
Adult
-
Aged
-
Biological Products / therapeutic use
-
COVID-19 / immunology
-
COVID-19 / prevention & control*
-
COVID-19 / virology
-
COVID-19 Vaccines / administration & dosage*
-
COVID-19 Vaccines / adverse effects
-
Colitis, Ulcerative / diagnosis
-
Colitis, Ulcerative / drug therapy*
-
Colitis, Ulcerative / immunology
-
Crohn Disease / diagnosis
-
Crohn Disease / drug therapy*
-
Crohn Disease / immunology
-
Electronic Health Records
-
Female
-
Gastrointestinal Agents / adverse effects
-
Gastrointestinal Agents / therapeutic use*
-
Humans
-
Immunocompromised Host
-
Immunosuppressive Agents / therapeutic use
-
Male
-
Middle Aged
-
Retrospective Studies
-
Risk Assessment
-
Risk Factors
-
Steroids / therapeutic use
-
Time Factors
-
Treatment Outcome
-
United States
-
Vaccination* / adverse effects
Substances
-
Biological Products
-
COVID-19 Vaccines
-
Gastrointestinal Agents
-
Immunosuppressive Agents
-
Steroids